Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease
Thématique(s) / pathologie(s)
- Maladie de Parkinson
Objectifs
Plus d'informations disponibles sur : https://clinicaltrials.gov/ct2/show/NCT03318523?term=BIOGEN&cond=BIIB054
Promoteur
Biogen
Publication(s) scientifique(s)
-
Lang AE et al. Trial of Cinpanemab in Early Parkinson's Disease. N Engl J Med. 2022 Aug 4;387(5):408-420.
Statut
Résultats publiés
